Multiple doses of secretin in the treatment of autism: a controlled study
- PMID:12113323
- DOI: 10.1080/080352502753711669
Multiple doses of secretin in the treatment of autism: a controlled study
Abstract
Dramatic effects on autistic behaviour after repeated injections of the gastrointestinal hormone secretin have been referred in a number of case reports. In the absence of curative and effective treatments for this disabling condition, this information has created new hope among parents. Although controlled studies on the effect of mainly one single dose have not documented any effect, many children still continue to receive secretin. Six children enrolled in a double-blind, placebo-controlled crossover study in which each child was its own control. Human synthetic secretin, mean dose 3.4 clinical units, and placebo were administered intravenously in randomized order every 4th wk, on three occasions each. The measurement instruments were the visual analogue scale (VAS) and the aberrant behaviour checklist (ABC). Statistically significant differences were found for placebo in 3 out of 6 children and for secretin in one child, using parental ratings only (VAS scores). Differences were small and lacked clinical significance, which was in accordance with the overall impression of the parents and teachers and visual inspection of graphs.
Conclusion: In this placebo-controlled study, multiple doses of secretin did not produce any symptomatic improvement.
Similar articles
- Secretin as a treatment for autism: a review of the evidence.Esch BE, Carr JE.Esch BE, et al.J Autism Dev Disord. 2004 Oct;34(5):543-56. doi: 10.1007/s10803-004-2549-6.J Autism Dev Disord. 2004.PMID:15628608Review.
- Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.Lightdale JR, Hayer C, Duer A, Lind-White C, Jenkins S, Siegel B, Elliott GR, Heyman MB.Lightdale JR, et al.Pediatrics. 2001 Nov;108(5):E90. doi: 10.1542/peds.108.5.e90.Pediatrics. 2001.PMID:11694674
- A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.Corbett B, Khan K, Czapansky-Beilman D, Brady N, Dropik P, Goldman DZ, Delaney K, Sharp H, Mueller I, Shapiro E, Ziegler R.Corbett B, et al.Clin Pediatr (Phila). 2001 Jun;40(6):327-31. doi: 10.1177/000992280104000604.Clin Pediatr (Phila). 2001.PMID:11824175Clinical Trial.
- Children with autistic spectrum disorders. I: comparison of placebo and single dose of human synthetic secretin.Levy SE, Souders MC, Wray J, Jawad AF, Gallagher PR, Coplan J, Belchic JK, Gerdes M, Mitchell R, Mulberg AE.Levy SE, et al.Arch Dis Child. 2003 Aug;88(8):731-6. doi: 10.1136/adc.88.8.731.Arch Dis Child. 2003.PMID:12876177Free PMC article.Clinical Trial.
- Intravenous secretin for autism spectrum disorder.Williams KW, Wray JJ, Wheeler DM.Williams KW, et al.Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003495. doi: 10.1002/14651858.CD003495.pub2.Cochrane Database Syst Rev. 2005.Update in:Cochrane Database Syst Rev. 2012 Apr 18;(4):CD003495. doi: 10.1002/14651858.CD003495.pub3.PMID:16034901Updated.Review.
Cited by
- Short report: Autistic gastrointestinal and eating symptoms treated with secretin: a subtype of autism.Pallanti S, Lassi S, La Malfa G, Campigli M, Di Rubbo R, Paolini G, Cesarali V.Pallanti S, et al.Clin Pract Epidemiol Ment Health. 2005 Nov 15;1:24. doi: 10.1186/1745-0179-1-24.Clin Pract Epidemiol Ment Health. 2005.PMID:16287506Free PMC article.
- Gastrointestinal factors in autistic disorder: a critical review.Erickson CA, Stigler KA, Corkins MR, Posey DJ, Fitzgerald JF, McDougle CJ.Erickson CA, et al.J Autism Dev Disord. 2005 Dec;35(6):713-27. doi: 10.1007/s10803-005-0019-4.J Autism Dev Disord. 2005.PMID:16267642Review.
- Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).Iffland M, Livingstone N, Jorgensen M, Hazell P, Gillies D.Iffland M, et al.Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.Cochrane Database Syst Rev. 2023.PMID:37811711Free PMC article.Review.
- Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial.King BH, Dukes K, Donnelly CL, Sikich L, McCracken JT, Scahill L, Hollander E, Bregman JD, Anagnostou E, Robinson F, Sullivan L, Hirtz D.King BH, et al.JAMA Pediatr. 2013 Nov;167(11):1045-52. doi: 10.1001/jamapediatrics.2013.2698.JAMA Pediatr. 2013.PMID:24061784Free PMC article.Clinical Trial.
- Secretin as a treatment for autism: a review of the evidence.Esch BE, Carr JE.Esch BE, et al.J Autism Dev Disord. 2004 Oct;34(5):543-56. doi: 10.1007/s10803-004-2549-6.J Autism Dev Disord. 2004.PMID:15628608Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources